Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wroclaw
Clinical trial register · Poland

Clinical Trials in Wroclaw, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 31 Wroclaw 29 Krakow 28 Katowice 23 Poznan 21
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Wroclaw Medical University30 Pfizer29 AstraZeneca26 Eli Lilly and Company22 Janssen Research & Development, LLC20 Clear sponsor filter
Site location
Warsaw31 Wroclaw29 Krakow28 Katowice23 Poznan21
All 50 locations
Target enrolment
to

Trials with a site in Wroclaw

29 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Pfizer
Phase 2
120
Wroclaw
2026-06-30
Recruiting
Pfizer
Phase 3
954
Bialystok, Gdansk, Lublin, Poznan, Wroclaw
2026-06-10
Recruiting
Pfizer
Phase 3
2,400
Krakow, Milówka, Bydgoszcz, Dziekanów Leśny, Poznan, Torun, Trzebnica, Wroclaw
2026-05-04
Recruiting
Pfizer
Phase 2/3
1,156
Katowice, Krakow, Tarnów, Warsaw, Wroclaw, Ostrowiec Świętokrzyski
2026-02-11
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Radom, Katowice, Kielce, Lodz, Lublin, Opole, Wroclaw, Tomaszów Mazowiecki
2026-01-06
Active, closed
Pfizer
Phase 2
128
Wroclaw, Gdansk, Ostrowiec Świętokrzyski, Rzeszów, Sosnowiec, Szczecin, Warsaw
2025-11-13
Recruiting
Pfizer
Phase 2
200
Warsaw, Chorzów, Gdansk, Lublin, Tarnów, Wroclaw
2025-10-30
Recruiting
Pfizer
Phase 3
1,000
Poznan, Wroclaw, Szczecin, Koszalin, Krakow, Lublin, Rzeszów
2025-09-28
Recruiting
Pfizer
Phase 3
140
Krakow, Wroclaw, Lublin, Warsaw, Katowice, Rzeszów, Lodz
2025-09-10
Recruiting
Pfizer
Phase 3
400
Bydgoszcz, Krakow, Wroclaw, Warsaw, Opole
2025-08-05
Active, closed
Pfizer
Phase 3
208
Krakow, Wroclaw, Lublin, Warsaw, Bialystok, Katowice, Ossy, Rzeszów
2025-07-31
Recruiting
Pfizer
Phase 2
252
Poznan, Krakow, Tarnów, Wroclaw, Bychawa, Sosnowiec
2025-05-20
Recruiting
Pfizer
Phase 3
674
Poznan, Krakow, Wroclaw, Lublin, Nowa Sól, Warsaw, Katowice, Sosnowiec
2025-04-01
Recruiting
Pfizer
Phase 3
723
Krakow, Oświęcim, Wroclaw, Lublin, Warsaw, Katowice
2025-03-11
Active, closed
Pfizer
Phase 3
636
Bydgoszcz, Krakow, Wroclaw, Lublin, Warsaw
2024-11-15
Recruiting
Pfizer
Phase 3
900
Krakow, Wroclaw, Lublin, Warsaw, Koszalin, Opole, Piotrkow Trybunalski
2024-10-22
Active, closed
Pfizer
Phase 3
600
Grudziądz, Torun, Krakow, Wroclaw, Opole, Koszalin
2024-10-21
Active, closed
Pfizer
Phase 2
507
Poznan, Krakow, Wroclaw, Katowice, Ostrowiec Świętokrzyski
2023-08-22
Recruiting
Pfizer
Phase 2
36
Warsaw, Katowice, Krakow, Szczecin, Wroclaw
2022-12-16
Recruiting
Pfizer
Phase 3
1,060
Wroclaw, Gdansk, Katowice
2022-11-10
Active, closed
Pfizer
Phase 3
854
Skórzewo, Katowice, Gdansk, Poznan, Warsaw, Wroclaw
2022-03-25
Recruiting
Pfizer
Phase 3
640
Poznan, Krakow, Wroclaw, Lublin, Warsaw, Katowice
2022-02-28
Recruiting
Pfizer
Phase 3
893
Bydgoszcz, Gdansk, Katowice, Poznan, Skorzewo, Warsaw, Wroclaw
2021-10-04
Active, closed
Pfizer
Phase 3
118
Warsaw, Lodz, Rzeszów, Wroclaw
2021-08-12
Recruiting
Pfizer
Phase 3
600
Katowice, Krakow, Poznan, Wroclaw
2021-04-28
Recruiting
Pfizer
Phase 3
2,100
Wroclaw, Katowice, Krakow, Poznan, Szczecin
2021-01-15
Active, closed
Pfizer
Phase 3
1,068
Gliwice, Grudziądz, Mysłowice, Piotrkow Trybunalski, Poznan, Skierniewice, Warsaw, Wroclaw
2019-12-30
Active, closed
Pfizer
Phase 3
896
Poznan, Wroclaw, Będzin, Bialystok, Gdansk, Gdynia, Jelenia Góra, Lodz
2019-09-05
Active, closed
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)
NCT02319837Hormone Sensitive Prostate Cancer, Prostate Cancer, Cancer of the Prostate
DrugsLupron·Eligard·Leuprorelin·Xtandi
Pfizer
Phase 3
1,068
Wroclaw, Torun, Gdansk, Słupsk
2014-12-17
Rows per page Showing 1–29 of 29
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 28 October 2026. https://priyalifescience.com/clinical-trials-poland/city/wroclaw

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 29 of those studies with a site in Wroclaw that also match the filters currently applied.

How many clinical trials are recruiting in Wroclaw?

19 of the 29 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wroclaw), 29 studies
PhaseStudiesRecruitingShare
Phase 3221475.9%
Phase 26420.7%
Phase 2/3113.4%

Most active sponsors

Lead sponsors with the most studies (Wroclaw)
Lead sponsorStudiesRecruiting
Pfizer2919
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.